Clinical trial
Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
NCT00002047 · Glaxo Wellcome, Industry · Completed
Key facts
| NCT number | NCT00002047 |
|---|---|
| Title | Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure |
| Official title | Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure |
| Lead sponsor | Glaxo Wellcome, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | Zidovudine |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: